MedTrace Logo

PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption

NCT00457158 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 399

Last updated 2012-11-27

No results posted yet for this study

Summary

The purpose of this study is to assess efficacy and safety of optional vena cava filter implanted 3 months in prevention of recurrent pulmonary embolism in patients presenting with acute pulmonary embolism associated with thrombotic risk factors

Conditions

Interventions

DEVICE

ALN optional filter

J1 : ALN optional filter M3 : ALN optional filter removed

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Fondation de France

    collaborator OTHER

  • Fondation de l'Avenir

    collaborator OTHER

  • ALN Implants Company

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Patrick MISMETTI, MD PhD · CHU de Saint-Etienne

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00457158 on ClinicalTrials.gov